Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is an intractable vascular disease characterized by a progressive increase in pulmonary vascular resistance caused by pulmonary vascular remodeling, which ultimately leads to right-sided heart failure. PAH remains incurable, despite the development of PAH-target...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraishi, Keizo, Kurahara, Lin Hai, Ishikawa, Kaori, Go, Tetsuhiko, Yokota, Naoya, Hu, Yaopeng, Fujita, Takayuki, Inoue, Ryuji, Hirano, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Society of Smooth Muscle Research 2022
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364263/
https://www.ncbi.nlm.nih.gov/pubmed/35944979
http://dx.doi.org/10.1540/jsmr.58.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364263/
https://www.ncbi.nlm.nih.gov/pubmed/35944979
http://dx.doi.org/10.1540/jsmr.58.50

Ejemplares similares